Miyamura T, Nishimura J, Yufu Y, Nawata H. Interaction of BCR-ABL with the retinoblastoma protein in Philadelphia chromosome-positive cell lines. Int. J. Hematol. February 1997, 65 (2): 115–21. PMID 9071815. doi:10.1016/S0925-5710(96)00539-7.
Welch PJ, Wang JY. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell. November 1993, 75 (4): 779–90. PMID 8242749. doi:10.1016/0092-8674(93)90497-E.
Lu J, Danielsen M. Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein. J. Biol. Chem. November 1998, 273 (47): 31528–33. PMID 9813067. doi:10.1074/jbc.273.47.31528.
Yeh S, Miyamoto H, Nishimura K, Kang H, Ludlow J, Hsiao P, Wang C, Su C, Chang C. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem. Biophys. Res. Commun. July 1998, 248 (2): 361–7. PMID 9675141. doi:10.1006/bbrc.1998.8974.
Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N, Libri V, Benassi B, Mattei E, Chersi A, Soddu S, Floridi A, Passananti C, Fanciulli M. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell. November 2002, 2 (5): 387–99. PMID 12450794. doi:10.1016/S1535-6108(02)00182-4.
Fanciulli M, Bruno T, Di Padova M, De Angelis R, Iezzi S, Iacobini C, Floridi A, Passananti C. Identification of a novel partner of RNA polymerase II subunit 11, Che-1, which interacts with and affects the growth suppression function of Rb. FASEB J. May 2000, 14 (7): 904–12. PMID 10783144.
Ge NL, Elferink CJ. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J. Biol. Chem. August 1998, 273 (35): 22708–13. PMID 9712901. doi:10.1074/jbc.273.35.22708.
Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG, Rosen EM. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene. August 2001, 20 (35): 4827–41. PMID 11521194. doi:10.1038/sj.onc.1204666.
Nishitani J, Nishinaka T, Cheng CH, Rong W, Yokoyama KK, Chiu R. Recruitment of the retinoblastoma protein to c-Jun enhances transcription activity mediated through the AP-1 binding site. J. Biol. Chem. February 1999, 274 (9): 5454–61. PMID 10026157. doi:10.1074/jbc.274.9.5454.
Gupta S, Luong MX, Bleuming SA, Miele A, Luong M, Young D, Knudsen ES, Van Wijnen AJ, Stein JL, Stein GS. Tumor suppressor pRB functions as a co-repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription. J. Cell. Physiol. September 2003, 196 (3): 541–56. PMID 12891711. doi:10.1002/jcp.10335.
Siegert JL, Rushton JJ, Sellers WR, Kaelin WG, Robbins PD. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity. Oncogene. November 2000, 19 (50): 5703–11. PMID 11126356. doi:10.1038/sj.onc.1203966.
Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. July 2000, 25 (3): 338–42. PMID 10888886. doi:10.1038/77124.
Pardo PS, Leung JK, Lucchesi JC, Pereira-Smith OM. MRG15, a novel chromodomain protein, is present in two distinct multiprotein complexes involved in transcriptional activation. J. Biol. Chem. December 2002, 277 (52): 50860–6. PMID 12397079. doi:10.1074/jbc.M203839200.
Taniura H, Taniguchi N, Hara M, Yoshikawa K. Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J. Biol. Chem. January 1998, 273 (2): 720–8. PMID 9422723. doi:10.1074/jbc.273.2.720.
Miyake S, Sellers WR, Safran M, Li X, Zhao W, Grossman SR, Gan J, DeCaprio JA, Adams PD, Kaelin WG. Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle. Mol. Cell. Biol. December 2000, 20 (23): 8889–902. PMC 86544 . PMID 11073989. doi:10.1128/MCB.20.23.8889-8902.2000.
Kim TA, Lim J, Ota S, Raja S, Rogers R, Rivnay B, Avraham H, Avraham S. NRP/B, a Novel Nuclear Matrix Protein, Associates With p110RB and Is Involved in Neuronal Differentiation. J. Cell Biol. May 1998, 141 (3): 553–66. PMC 2132755 . PMID 9566959. doi:10.1083/jcb.141.3.553.
Craven RJ, Cance WG, Liu ET. The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb. Cancer Res. September 1995, 55 (18): 3969–72. PMID 7664264.
Lavender P, Vandel L, Bannister AJ, Kouzarides T. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene. June 1997, 14 (22): 2721–8. PMID 9178770. doi:10.1038/sj.onc.1201243.
Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. January 2000, 24 (1): 88–91. PMID 10615135. doi:10.1038/71750.
Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz RL, Muscat GE, Giordano A, Kedes L, Wang JY, Sartorelli V. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell. October 2001, 8 (4): 885–97. PMID 11684023. doi:10.1016/S1097-2765(01)00373-2.
Wang S, Fusaro G, Padmanabhan J, Chellappan SP. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene. December 2002, 21 (55): 8388–96. PMID 12466959. doi:10.1038/sj.onc.1205944.
Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril MB, Miard S, Auwerx J. The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev. Cell. December 2002, 3 (6): 903–10. PMID 12479814. doi:10.1016/S1534-5807(02)00360-X.
Radulescu RT, Bellitti MR, Ruvo M, Cassani G, Fassina G. Binding of the LXCXE Insulin Motif to a Hexapeptide Derived from Retinoblastoma Protein. Biochemical and Biophysical Research Communications. January 1995, 206 (1): 97–102. PMID 7818556. doi:10.1006/bbrc.1995.1014.
Chan SW, Hong W. Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription. J. Biol. Chem. July 2001, 276 (30): 28402–12. PMID 11358960. doi:10.1074/jbc.M100313200.
Leung JK, Berube N, Venable S, Ahmed S, Timchenko N, Pereira-Smith OM. MRG15 activates the B-myb promoter through formation of a nuclear complex with the retinoblastoma protein and the novel protein PAM14. J. Biol. Chem. October 2001, 276 (42): 39171–8. PMID 11500496. doi:10.1074/jbc.M103435200.
Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. February 1993, 72 (3): 309–24. PMID 8381715. doi:10.1016/0092-8674(93)90110-C.
Goo YH, Na SY, Zhang H, Xu J, Hong S, Cheong J, Lee SK, Lee JW. Interactions between activating signal cointegrator-2 and the tumor suppressor retinoblastoma in androgen receptor transactivation. J. Biol. Chem. February 2004, 279 (8): 7131–5. PMID 14645241. doi:10.1074/jbc.M312563200.
Takemura M, Kitagawa T, Izuta S, Wasa J, Takai A, Akiyama T, Yoshida S. Phosphorylated retinoblastoma protein stimulates DNA polymerase alpha. Oncogene. November 1997, 15 (20): 2483–92. PMID 9395244. doi:10.1038/sj.onc.1201431.
Simons A, Melamed-Bessudo C, Wolkowicz R, Sperling J, Sperling R, Eisenbach L, Rotter V. PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb. Oncogene. January 1997, 14 (2): 145–55. PMID 9010216. doi:10.1038/sj.onc.1200825.
Wang S, Nath N, Adlam M, Chellappan S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene. June 1999, 18 (23): 3501–10. PMID 10376528. doi:10.1038/sj.onc.1202684.
Qian YW, Lee EY. Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast. J. Biol. Chem. October 1995, 270 (43): 25507–13. PMID 7503932. doi:10.1074/jbc.270.43.25507.
Fusco C, Reymond A, Zervos AS. Molecular cloning and characterization of a novel retinoblastoma-binding protein. Genomics. August 1998, 51 (3): 351–8. PMID 9721205. doi:10.1006/geno.1998.5368.
Woitach JT, Zhang M, Niu CH, Thorgeirsson SS. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Nat. Genet. August 1998, 19 (4): 371–4. PMID 9697699. doi:10.1038/1258.
Ji P, Jiang H, Rekhtman K, Bloom J, Ichetovkin M, Pagano M, Zhu L. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell. October 2004, 16 (1): 47–58. PMID 15469821. doi:10.1016/j.molcel.2004.09.029.
Wang H, Bauzon F, Ji P, Xu X, Sun D, Locker J, Sellers RS, Nakayama K, Nakayama KI, Cobrinik D, Zhu L. Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice. Nat. Genet. January 2010, 42 (1): 83–8. PMC 2990528 . PMID 19966802. doi:10.1038/ng.498.
Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T. Rb targets histone H3 methylation and HP1 to promoters. Nature. August 2001, 412 (6846): 561–5. PMID 11484059. doi:10.1038/35087620.
Chang KH, Chen Y, Chen TT, Chou WH, Chen PL, Ma YY, Yang-Feng TL, Leng X, Tsai MJ, O'Malley BW, Lee WH. A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. U.S.A. August 1997, 94 (17): 9040–5. PMC 23019 . PMID 9256431. doi:10.1073/pnas.94.17.9040.
Hannan KM, Hannan RD, Smith SD, Jefferson LS, Lun M, Rothblum LI. Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1. Oncogene. October 2000, 19 (43): 4988–99. PMID 11042686. doi:10.1038/sj.onc.1203875.
Blanchette P, Gilchrist CA, Baker RT, Gray DA. Association of UNP, a ubiquitin-specific protease, with the pocket proteins pRb, p107 and p130. Oncogene. September 2001, 20 (39): 5533–7. PMID 11571651. doi:10.1038/sj.onc.1204823.
視網膜母細胞瘤蛋白引用了美國國家醫學圖書館提供的資料,這些資料屬於公共領域。